v3.25.4
INTANGIBLE ASSETS—NET - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 569,142 $ 663,902
Accumulated Amortization (142,044) (137,464)
Net Carrying Amount $ 427,098 $ 526,438
Trademarks and trade name    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful Lives (Years) 14 years 14 years
Gross Carrying Amount $ 439,121 $ 559,875
Accumulated Amortization (99,355) (102,169)
Net Carrying Amount $ 339,766 $ 457,706
Customer/distributor relationships    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful Lives (Years) 11 years 11 years
Gross Carrying Amount $ 34,634 $ 36,000
Accumulated Amortization (7,795) (6,449)
Net Carrying Amount $ 26,839 $ 29,551
Tretinoin distribution and supply agreement    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful Lives (Years) 5 years 5 years
Gross Carrying Amount $ 37,176 $ 38,900
Accumulated Amortization (24,942) (18,885)
Net Carrying Amount $ 12,234 $ 20,015
Formulations    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful Lives (Years) 8 years 8 years
Gross Carrying Amount $ 25,303 $ 28,900
Accumulated Amortization (9,921) (9,943)
Net Carrying Amount $ 15,382 $ 18,957
Novaestiq distribution agreement    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful Lives (Years) 20 years  
Gross Carrying Amount $ 32,635  
Accumulated Amortization 0  
Net Carrying Amount $ 32,635  
Patents    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average Useful Lives (Years) 20 years 20 years
Gross Carrying Amount $ 273 $ 227
Accumulated Amortization (31) (18)
Net Carrying Amount $ 242 $ 209